Literature DB >> 32761272

The bony obliteration tympanoplasty in cholesteatoma: safety, hygiene and hearing outcome: allograft versus autograft tympanic membrane reconstruction.

Huibert F van Waegeningh1, Joost J S van Dinther2, Robby Vanspauwen2, Andrzej Zarowski2, Erwin Offeciers2.   

Abstract

OBJECTIVE: To evaluate early results on hygiene, safety and functional outcome in a population undergoing a canal wall up technique with bony obliteration of the mastoid and epitympanic space (CWU-BOT) for extensive cholesteatoma, performed by a single surgeon. This study compares different techniques of tympanic membrane reconstruction, viz. allografts and autografts. PATIENTS: A consecutive series of 61 ears with acquired cholesteatoma treated with primary or revision CWU-BOT surgery from 2009 to 2014. INTERVENTION: Obliteration was performed by the use of cortical bone-chips and bone pâté. Patients were followed up with micro-otoscopy and MRI with diffusion-weighted imaging. Ossicular reconstruction was performed using a remodelled autologous or allogenic incus or malleus. MAIN OUTCOME MEASURES: Residual and recurrence rate and short- and mid-term hearing outcome prior to any revision tympanoplasty were analysed, the effect of type of tympanic membrane reconstruction was considered.
RESULTS: 44 Ears were primary cholesteatoma cases, 17 cases were referred for revision surgery. Mean postoperative follow up was 45 months (SD 18.08) and mean follow-up until the last non-EP DW MRI 42 months (SD 17.72). Recurrent disease was present in 3%, no residual disease was present. An AC gain was seen in 75% of all ears undergoing ossicular reconstruction.
CONCLUSION: Reproducible safety, hygiene and hearing results with limited recurrence and residual disease can be obtained by younger otologic surgeons performing the BOT-CWU for extensive cholesteatoma while using a variety of grafts for tympano-ossicular reconstruction. The tympano-ossicular allograft nevertheless shows superior hearing results when a mobile intact stapes is present. LEVEL OF EVIDENCE: Level 4.

Entities:  

Keywords:  Cholesteatoma; Ear; Mastoid; Middle; Obliteration; Surgery

Mesh:

Year:  2020        PMID: 32761272     DOI: 10.1007/s00405-020-06258-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  2 in total

1.  Single-shot, turbo spin-echo, diffusion-weighted imaging versus spin-echo-planar, diffusion-weighted imaging in the detection of acquired middle ear cholesteatoma.

Authors:  B De Foer; J-P Vercruysse; B Pilet; J Michiels; R Vertriest; M Pouillon; T Somers; J W Casselman; E Offeciers
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

2.  The cholesteatomatous ear one year after surgery with obliteration technique.

Authors:  U Mercke
Journal:  Am J Otol       Date:  1987-11
  2 in total
  1 in total

1.  A retrospective analysis of hearing after cholesteatoma surgery: the bony obliteration tympanoplasty versus canal wall up and canal wall down without mastoid obliteration.

Authors:  Hylke F E van der Toom; Marc P van der Schroeff; Mick Metselaar; Anne van Linge; Jantien L Vroegop; Robert J Pauw
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-04-10       Impact factor: 3.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.